Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
FDA Office of Orphan Products Development Clinical Trials Info presented on Clinical Trials Search is not designed to be a substitute for proven health advice, calls or professional assistance by using a real physician. We are not mDs. Always confer with your doctor on FDA Office of Orphan Products Development clinical studies. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. FDA Office of Orphan Products Development Clinical research trials and FDA Office of Orphan Products Development health trials occur in a lot of of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectivity of new does drugs. The function of the studies / undertakings is to figure out specific human health questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations like FDA Office of Orphan Products Development to find cures for all forms of conditions. FDA Office of Orphan Products Development Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the general public. Many times the participants recieve professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a FDA Office of Orphan Products Development clinical trial. Participants oftentimes get the most expert healthcare possible for their condition. Risks are a reality, nevertheless, and may include extra or frequent doctor calls, healthcare risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with exacting guidelines to protect clinical trials subjects.

Home > "F" Clinical Trials Sponsors > FDA Office of Orphan Products Development Clinical Trials

FDA Office of Orphan Products Development Clinical Trials



A Controlled Study of Olanzapine in Children with Autism
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

ADI-PEG in Patients With Metastatic Melanoma
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Androgen Replacement Therapy in Women with Hypopituitarism
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Assessment of Chronic Guillain-Barre Syndrome Improvement with Use of 4-aminopyridine
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Clofarabine in Chronic Lymphocytic Leukemia
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Clotrimazole Enemas for Pouchitis in Children and Adults
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Controlled Trial of 4-Aminosalicylic Acid in Patients with Small Bowel Crohn's Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Deep Brain Stimulation in Treating Patients With Dystonia
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

GM-CSF in Patients With Pulmonary Alveolar Proteinosis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Intraperitoneal Floxuridine in Gastric Carcinoma
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Intravenous Pertussis Immune Globulin in Patients with Severe Childhood Pertussis Infection
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Intraventricular rt-PA in Patients with Intraventricular Hemorrhage
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Keratinocyte Growth Factor to Prevent Acute GVHD
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

L-glutamine Therapy for Sickle Cell Anemia
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Leuprolide in Determining the Cause of Gonadotropin Deficiency
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Leuprolide in Treating Adults With Hypogonadotropism
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Liothyronine in Children with Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Minocycline in Patients with Huntington's Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Novel Adjuvants for Peptide-Based Melanoma Vaccines
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase I Randomized Study of CPX for the Treatment of Adult Patients with Mild Cystic Fibrosis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults with Partial Ornithine Transcarbamylase Deficiency
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients with Acute Renal Failure
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase I Study of Vasoactive Intestinal Peptide in Patients with Acute Respiratory Distress Syndrome and Sepsis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients with Gaucher's Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Randomized Study of Cultured Skin Substitutes versus Split Thickness Skin Grafts in Patients with Severe Burn Injuries
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Study of Amithiozone (Thiacetazone) for Patients with Mycobacterium Avium Complex Pulmonary Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients with Enterocutaneous Fistulae as a Complication of Crohn's Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of Sodium Dichloroacetate in Children with Congenital Lactic Acidosis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of the Inhalation of Tobramycin in Patients with Cystic Fibrosis
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Phase III Randomized Study of UT-15 in Patients with Primary Pulmonary Hypertension
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development



FDA Office of Orphan Products Development Clinical Trials

Modify your Search

Other "F" Clinical Trials Sponsors:

Fairview University Medical Center
Favrille
Fda Office Of Orphan Products Development
Federation Francophone De Cancerologie Digestive
Federation Nationale Des Centres De Lutte Contre Le Cancer
Ferx
Fibrogen, Inc.
Fisons
Focus Surgery
Food And Drug Administration (fda)
Fox Chase Cancer Center
Fred Hutchinson Cancer Research Center
Free Radical Sciences
Fujisawa Healthcare, Inc.
Fujisawa Pharmaceutical


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103